SG Stock MarketDetailed Quotes

Hyphens Pharma (1J5)

Watchlist
  • 0.350
  • 0.0000.00%
10min DelayMarket Closed Apr 30 16:56 CST
108.10MMarket Cap18.42P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

1J5 Hyphens Pharma

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
Total revenue
-9.24%177.37M
14.55%195.42M
5.10%170.6M
28.94%162.32M
4.06%125.88M
1.29%120.98M
-14.77%27.9M
2.40%31.44M
4.13%30.2M
16.43%31.44M
Cost of revenue
-16.46%105.19M
15.84%125.91M
9.23%108.69M
27.90%99.51M
0.59%77.8M
0.74%77.34M
-23.57%15.72M
6.37%21.09M
6.06%20M
17.17%20.54M
Gross profit
3.85%72.18M
12.29%69.51M
-1.45%61.9M
30.63%62.81M
10.19%48.08M
2.27%43.64M
0.10%12.18M
-4.84%10.35M
0.53%10.2M
15.06%10.9M
Operating expense
3.62%56.67M
9.83%54.69M
5.19%49.79M
19.53%47.34M
14.47%39.6M
1.10%34.6M
-11.02%8.65M
3.23%8.86M
4.81%8.62M
10.09%8.47M
Staff costs
5.85%30.23M
14.82%28.56M
3.82%24.87M
--23.96M
----
----
----
----
----
----
Selling and administrative expenses
0.86%22.87M
5.54%22.67M
-8.15%21.48M
-41.58%23.39M
9.20%40.03M
5.93%36.66M
5.98%10.71M
3.23%8.86M
4.81%8.62M
10.09%8.47M
-Selling and marketing expense
-0.24%18.28M
4.88%18.33M
4.00%17.48M
-40.82%16.8M
7.05%28.39M
6.79%26.52M
3.25%7.83M
2.18%6.33M
3.90%6.14M
20.84%6.24M
-General and administrative expense
5.53%4.58M
8.41%4.34M
-39.17%4.01M
-43.43%6.58M
14.81%11.64M
3.75%10.14M
14.17%2.89M
5.93%2.54M
7.15%2.49M
-11.87%2.23M
Research and development costs
-36.57%255K
-8.43%402K
81.40%439K
--242K
----
----
----
----
----
----
Depreciation and amortization
-7.99%2.81M
9.19%3.06M
--2.8M
----
----
----
----
----
----
----
-Depreciation
-12.18%1.77M
-4.01%2.01M
--2.1M
----
----
----
----
----
----
----
-Amortization
0.10%1.04M
48.58%1.04M
--702K
----
----
----
----
----
----
----
Rent and land expenses
-22.46%221K
-33.26%285K
76.45%427K
--242K
----
----
----
----
----
----
Other operating expenses
710.53%616K
606.67%76K
-165.22%-15K
1,050.00%23K
112.50%2K
73.33%-16K
----
----
----
----
Total other operating income
-7.54%331K
71.29%358K
-59.42%209K
18.94%515K
-78.86%433K
522.49%2.05M
----
----
----
----
Operating profit
4.70%15.51M
22.37%14.82M
-21.74%12.11M
82.44%15.47M
-6.17%8.48M
6.98%9.04M
44.11%3.54M
-35.10%1.49M
-17.80%1.58M
36.45%2.44M
Net non-operating interest income expense
-12.05%-465K
-758.73%-415K
132.14%63K
-833.33%-196K
-130.00%-21K
268.42%70K
17.60%147K
18.75%-26K
12.50%-28K
45.24%-23K
Non-operating interest income
-63.33%55K
-56.01%150K
711.90%341K
-43.24%42K
-58.89%74K
14.65%180K
----
----
----
----
Non-operating interest expense
-7.96%520K
103.24%565K
16.81%278K
150.53%238K
-13.64%95K
-20.29%110K
3.13%33K
-18.75%26K
-12.50%28K
-45.24%23K
Net investment income
-695.39%-2.76M
75.44%-347K
-53.09%-1.41M
-301.97%-923K
872.34%457K
149.47%47K
Gain/Loss on financial instruments designated as cash flow hedges
-238.89%-250K
180K
0
Gain/Loss on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
14.98%545K
2,688.24%474K
17K
0
Special income /charges
-211.43%-3.98M
-72.80%-1.28M
-37.62%-739K
20.80%-537K
66.89%-678K
-430.57%-2.05M
Less:Restructuring and mergern&acquisition
----
--0
---165K
--0
----
----
----
----
----
----
Less:Other special charges
1,860.00%88K
0.00%-5K
-266.67%-5K
-25.00%3K
200.00%4K
-180.00%-4K
----
----
----
----
Less:Write off
203.35%3.89M
41.03%1.28M
70.22%909K
-20.77%534K
-67.15%674K
438.58%2.05M
----
----
----
----
Other non-operating income /expenses
-44.30%386K
693K
-763.83%-406K
568.21%1.01M
353.62%175K
Income before tax
-37.79%8.06M
22.66%12.96M
-26.07%10.57M
73.10%14.29M
16.15%8.26M
-11.01%7.11M
-56.08%906K
-52.33%1.05M
25.49%2.56M
54.57%2.59M
Income tax
-7.56%1.95M
5.99%2.1M
-31.12%1.99M
104.40%2.88M
49.21%1.41M
-35.14%945K
-132.16%-128K
-49.51%206K
-0.74%402K
89.02%465K
Net income
-43.65%6.12M
26.52%10.86M
-24.80%8.58M
66.65%11.41M
11.08%6.85M
-5.62%6.16M
-37.90%1.03M
-52.97%847K
31.99%2.16M
48.64%2.12M
Net income continuous operations
-43.65%6.12M
26.52%10.86M
-24.80%8.58M
66.65%11.41M
11.08%6.85M
-5.62%6.16M
-37.90%1.03M
-52.97%847K
31.99%2.16M
48.64%2.12M
Noncontrolling interests
-58.70%273K
5,408.33%661K
-79.31%12K
58K
0
Net income attributable to the company
-42.67%5.84M
18.98%10.19M
-24.52%8.57M
65.80%11.35M
11.08%6.85M
-5.62%6.16M
-37.90%1.03M
-52.97%847K
31.99%2.16M
48.64%2.12M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-42.67%5.84M
18.98%10.19M
-24.52%8.57M
65.80%11.35M
11.08%6.85M
-5.62%6.16M
-37.90%1.03M
-52.97%847K
31.99%2.16M
48.64%2.12M
Gross dividend payment
Basic earnings per share
-42.73%0.0189
19.13%0.033
-24.73%0.0277
62.11%0.0368
10.73%0.0227
-5.53%0.0205
-38.18%0.0034
-53.33%0.0028
33.33%0.0072
47.92%0.0071
Diluted earnings per share
-42.59%0.0186
16.97%0.0324
-24.32%0.0277
61.23%0.0366
10.73%0.0227
-5.53%0.0205
-38.18%0.0034
-53.33%0.0028
33.33%0.0072
47.92%0.0071
Dividend per share
74.42%0.015
-22.52%0.0086
65.67%0.0111
8.06%0.0067
-38.00%0.0062
81.82%0.01
0
0
81.82%0.01
0
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020
Total revenue -9.24%177.37M14.55%195.42M5.10%170.6M28.94%162.32M4.06%125.88M1.29%120.98M-14.77%27.9M2.40%31.44M4.13%30.2M16.43%31.44M
Cost of revenue -16.46%105.19M15.84%125.91M9.23%108.69M27.90%99.51M0.59%77.8M0.74%77.34M-23.57%15.72M6.37%21.09M6.06%20M17.17%20.54M
Gross profit 3.85%72.18M12.29%69.51M-1.45%61.9M30.63%62.81M10.19%48.08M2.27%43.64M0.10%12.18M-4.84%10.35M0.53%10.2M15.06%10.9M
Operating expense 3.62%56.67M9.83%54.69M5.19%49.79M19.53%47.34M14.47%39.6M1.10%34.6M-11.02%8.65M3.23%8.86M4.81%8.62M10.09%8.47M
Staff costs 5.85%30.23M14.82%28.56M3.82%24.87M--23.96M------------------------
Selling and administrative expenses 0.86%22.87M5.54%22.67M-8.15%21.48M-41.58%23.39M9.20%40.03M5.93%36.66M5.98%10.71M3.23%8.86M4.81%8.62M10.09%8.47M
-Selling and marketing expense -0.24%18.28M4.88%18.33M4.00%17.48M-40.82%16.8M7.05%28.39M6.79%26.52M3.25%7.83M2.18%6.33M3.90%6.14M20.84%6.24M
-General and administrative expense 5.53%4.58M8.41%4.34M-39.17%4.01M-43.43%6.58M14.81%11.64M3.75%10.14M14.17%2.89M5.93%2.54M7.15%2.49M-11.87%2.23M
Research and development costs -36.57%255K-8.43%402K81.40%439K--242K------------------------
Depreciation and amortization -7.99%2.81M9.19%3.06M--2.8M----------------------------
-Depreciation -12.18%1.77M-4.01%2.01M--2.1M----------------------------
-Amortization 0.10%1.04M48.58%1.04M--702K----------------------------
Rent and land expenses -22.46%221K-33.26%285K76.45%427K--242K------------------------
Other operating expenses 710.53%616K606.67%76K-165.22%-15K1,050.00%23K112.50%2K73.33%-16K----------------
Total other operating income -7.54%331K71.29%358K-59.42%209K18.94%515K-78.86%433K522.49%2.05M----------------
Operating profit 4.70%15.51M22.37%14.82M-21.74%12.11M82.44%15.47M-6.17%8.48M6.98%9.04M44.11%3.54M-35.10%1.49M-17.80%1.58M36.45%2.44M
Net non-operating interest income expense -12.05%-465K-758.73%-415K132.14%63K-833.33%-196K-130.00%-21K268.42%70K17.60%147K18.75%-26K12.50%-28K45.24%-23K
Non-operating interest income -63.33%55K-56.01%150K711.90%341K-43.24%42K-58.89%74K14.65%180K----------------
Non-operating interest expense -7.96%520K103.24%565K16.81%278K150.53%238K-13.64%95K-20.29%110K3.13%33K-18.75%26K-12.50%28K-45.24%23K
Net investment income -695.39%-2.76M75.44%-347K-53.09%-1.41M-301.97%-923K872.34%457K149.47%47K
Gain/Loss on financial instruments designated as cash flow hedges -238.89%-250K180K0
Gain/Loss on derecognition of available-for-sale financial assets
Income from associates and other participating interests 014.98%545K2,688.24%474K17K0
Special income /charges -211.43%-3.98M-72.80%-1.28M-37.62%-739K20.80%-537K66.89%-678K-430.57%-2.05M
Less:Restructuring and mergern&acquisition ------0---165K--0------------------------
Less:Other special charges 1,860.00%88K0.00%-5K-266.67%-5K-25.00%3K200.00%4K-180.00%-4K----------------
Less:Write off 203.35%3.89M41.03%1.28M70.22%909K-20.77%534K-67.15%674K438.58%2.05M----------------
Other non-operating income /expenses -44.30%386K693K-763.83%-406K568.21%1.01M353.62%175K
Income before tax -37.79%8.06M22.66%12.96M-26.07%10.57M73.10%14.29M16.15%8.26M-11.01%7.11M-56.08%906K-52.33%1.05M25.49%2.56M54.57%2.59M
Income tax -7.56%1.95M5.99%2.1M-31.12%1.99M104.40%2.88M49.21%1.41M-35.14%945K-132.16%-128K-49.51%206K-0.74%402K89.02%465K
Net income -43.65%6.12M26.52%10.86M-24.80%8.58M66.65%11.41M11.08%6.85M-5.62%6.16M-37.90%1.03M-52.97%847K31.99%2.16M48.64%2.12M
Net income continuous operations -43.65%6.12M26.52%10.86M-24.80%8.58M66.65%11.41M11.08%6.85M-5.62%6.16M-37.90%1.03M-52.97%847K31.99%2.16M48.64%2.12M
Noncontrolling interests -58.70%273K5,408.33%661K-79.31%12K58K0
Net income attributable to the company -42.67%5.84M18.98%10.19M-24.52%8.57M65.80%11.35M11.08%6.85M-5.62%6.16M-37.90%1.03M-52.97%847K31.99%2.16M48.64%2.12M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -42.67%5.84M18.98%10.19M-24.52%8.57M65.80%11.35M11.08%6.85M-5.62%6.16M-37.90%1.03M-52.97%847K31.99%2.16M48.64%2.12M
Gross dividend payment
Basic earnings per share -42.73%0.018919.13%0.033-24.73%0.027762.11%0.036810.73%0.0227-5.53%0.0205-38.18%0.0034-53.33%0.002833.33%0.007247.92%0.0071
Diluted earnings per share -42.59%0.018616.97%0.0324-24.32%0.027761.23%0.036610.73%0.0227-5.53%0.0205-38.18%0.0034-53.33%0.002833.33%0.007247.92%0.0071
Dividend per share 74.42%0.015-22.52%0.008665.67%0.01118.06%0.0067-38.00%0.006281.82%0.010081.82%0.010
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -